Liege 2019 – Radiopharmacy Programme
 |
Saturday, May 11
|
| FANC/AFCN: Application submitted | |
WELCOME |
Common to all attendeesLocation: Grand foyer |
| 8:40-8:50 |
WELCOME BY BELNUC PRESIDENT Pieter De Bondt OLV Ziekenhuis Aalst, Belgium |
COMMON OPENING SESSION |
Medical, radiopharmacy and physics common sessionLocation: Auditorium Reine Elisabeth |
| 9:00-10:30 | OPPORTUNITIES FOR PATIENT CARE |
| Chaired by Prof Guy Bormans, Prof Michel Koole and Prof Dr Patrick Flamen | |
| 9:00-9:30 | Developments in total body PET/CT systems
Prof Dr Stefaan Vandenberghe MEDISIP-ELIS-IBITECH-IMEC, Ghent University, Belgium |
| 9:30-10:00 | PSMA targeted radioligand therapy in prostate cancer: Towards the future.
Dr Andrei Gafita Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany |
| 10:00-10:30 | Holmium-166 Radioembolization
Prof Dr M.G.E.H. (Marnix) Lam Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands |
COFFEE BREAK |
10:30-11:00Location: Grand foyer |
RADIOCHEMISTRY |
Radiopharmacy and radiochemistry sessionLocation: Mosane 5 |
| RadioChemistry | |
| Chaired by Filip de Vos | |
| 11:00-11:05 | Welcome Radiopharmacy session
Filip de Vos, UGhent, Ghent, Belgium Zéna Wimana, Nuclear Medicine Department, Institut Jules Bordet, Brussels, Belgium |
| 11:05-11:25 | Flow chemistry and chemometrics: an innovative way to optimize the radiopharmaceutical R&D
Mallory Salvé Nuclear Medicine and Oncological Imaging Division, CHU of Liege, Liège,Belgium GIGA-CRC In VIVO Imaging, University of Liège, Liège, Belgium |
| 11:25: 12:10 | Gallium-68 produced by cyclotron vs generator: pros and cons
Simon Lacroix, Nuclear Medicine Department, Hôpital Erasme, Brussels, Belgium Zéna Wimana, Nuclear Medicine Department, Institut Jules Bordet, Brussels, Belgium |
LUNCH &MEET THE SPONSORS |
12:10-14:00Location: Grand foyer |
POSTER SESSION |
Location: Grand foyer |
| 12:10-12:50 | MEET THE AUTHOR |
BAYER SPONSORED SYMPOSIUM |
Location: Auditorium 250 |
| 13:10-13-55 | SATURDAY NOON LECTURE ON RADIUM-223 |
TARGET |
Radiopharmacy and radiochemistry sessionLocation: Mosane 5 |
| Chaired by Vicky Caveliers | |
| 14:00-14:30 | How to investigate the radiobiological effects of radionuclide therapies: Models, techniques and tools
Sarah Baatout Radiobiology unit, SCK•CEN, Mol, Belgium
|
| 14:30-15:30 | SCIENTIFIC ABSTRACTS |
| 14:30-14:42 | Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK•CEN), Mol, Belgium In vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), Brussels, Belgium |
| 14:42-14:54 | Understanding the radiobiology of targeted radionuclide therapy with 177Lu-DOTATATE
Wendy Delbart Nuclear Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Belgium |
| 14:54-15:06 | Development and evaluation of selective PET probes for imaging of caspase-3 activity
Lucas Beroske Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium Department of Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium |
| 15:06-15:18 | Comparison of [68Ga]PSMA-11 and [18F]PSMA-11 for in vivo PET/CT imaging of prostate cancer
Sarah Piron Ghent University, Lab Radiopharmacy, Ghent, Belgium |
| 15:18-15:30 | Discrimination between glioblastoma and radionecrosis using preclinical [18F]FET, 2-[18F]FELP and [18F]FDG PET in rats
Jeroen Verhoeven Laboratory of Radiopharmacy, Ghent University, Belgium |
COFFEE BREAK |
15:30-16:00Location: Grand foyer |
Radiopharmacy GMP/Regulations |
Radiopharmacy and radiochemistry sessionLocation: Mosane 5 |
| Radiopharmacy GMP/Regulations | |
| Chaired by Dominique Vanderghinste | |
| 16:00-16:25 | Pharmaceutical Quality System
Kim Serdons Nuclear Medicine Department, UZ Leuven, Leuven, Belgium |
| 16:25-16:55 | GMP: update and changes in Annex 1
Julie Cousaert Nuclear Medicine Department, UZ Brussel, Brussel, Belgium |
COMMON CLOSING SESSION |
Medical, radiopharmacy and physics common sessionLocation: Auditorium Reine Elisabeth |
| 17:00-17:30 | RADIONUCLIDE THERAPY |
| Chaired by Dr Marcel Stokkel and Sarah Baatout | |
| 17:00-17:30 | Radiolabeled Nanobodies for targeted α-particle therapy
Prof Matthias D’Huyvetter In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Belgium |
2019 BELNUC AWARDS CEREMONY |
Common sessionLocation: Auditorium Reine Elisabeth |
| 17:30-18:00 | BELNUC AWARD CEREMONY |
| 2019 BELNUC AWARD | |
| 2019 YOUNG NUCLEARIST AWARD | |
| 2019 BEST ORAL PRESENTATION IN RADIOPHARMACY & RADIOCHEMISTRY | |
| 2019 BEST ORAL PRESENTATION IN PHYSICS & ENGINEERING | |
| 2019 TECHNOLOGIST SECTION AWARD | |